Wellington Management Group LLP Decreases Position in The Clorox Company (NYSE:CLX)

Wellington Management Group LLP decreased its stake in shares of The Clorox Company (NYSE:CLX - Free Report) by 69.2% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 3,428 shares of the company's stock after selling 7,703 shares during the quarter. Wellington Management Group LLP's holdings in Clorox were worth $558,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the stock. Insight Folios Inc grew its stake in shares of Clorox by 3.0% in the 3rd quarter. Insight Folios Inc now owns 2,195 shares of the company's stock worth $358,000 after buying an additional 63 shares in the last quarter. Fiduciary Group LLC grew its position in Clorox by 0.4% in the second quarter. Fiduciary Group LLC now owns 19,050 shares of the company's stock worth $2,600,000 after acquiring an additional 72 shares in the last quarter. GHP Investment Advisors Inc. grew its position in Clorox by 2.0% in the second quarter. GHP Investment Advisors Inc. now owns 3,634 shares of the company's stock worth $496,000 after acquiring an additional 72 shares in the last quarter. SPC Financial Inc. increased its stake in Clorox by 2.2% during the second quarter. SPC Financial Inc. now owns 3,485 shares of the company's stock worth $476,000 after acquiring an additional 75 shares during the last quarter. Finally, Massmutual Trust Co. FSB ADV raised its position in Clorox by 17.2% during the third quarter. Massmutual Trust Co. FSB ADV now owns 510 shares of the company's stock valued at $83,000 after purchasing an additional 75 shares during the period. 78.53% of the stock is owned by hedge funds and other institutional investors.

Clorox Stock Performance

NYSE:CLX traded up $0.31 during trading hours on Friday, hitting $164.44. 4,020,577 shares of the company were exchanged, compared to its average volume of 1,241,661. The company's 50 day moving average price is $164.16 and its 200-day moving average price is $152.71. The stock has a market capitalization of $20.35 billion, a price-to-earnings ratio of 57.30, a PEG ratio of 3.04 and a beta of 0.42. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $171.37. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62.

Clorox (NYSE:CLX - Get Free Report) last released its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The firm had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.64 billion. During the same period in the prior year, the firm earned $0.49 EPS. The firm's revenue was up 27.0% on a year-over-year basis. As a group, research analysts forecast that The Clorox Company will post 6.85 earnings per share for the current year.

Clorox Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be issued a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a yield of 2.97%. The ex-dividend date is Wednesday, January 29th. Clorox's dividend payout ratio (DPR) is 170.03%.

Analyst Ratings Changes

A number of equities analysts recently commented on CLX shares. JPMorgan Chase & Co. lifted their price target on shares of Clorox from $148.00 to $174.00 and gave the stock a "neutral" rating in a research note on Friday, October 11th. Citigroup boosted their target price on Clorox from $165.00 to $170.00 and gave the company a "neutral" rating in a research report on Friday, September 6th. DA Davidson increased their price target on Clorox from $153.00 to $171.00 and gave the stock a "neutral" rating in a report on Monday, November 4th. Evercore ISI dropped their price objective on Clorox from $140.00 to $139.00 and set an "underperform" rating for the company in a report on Monday, October 14th. Finally, Jefferies Financial Group upgraded Clorox from a "hold" rating to a "buy" rating and increased their target price for the stock from $174.00 to $187.00 in a research note on Tuesday, October 1st. Five research analysts have rated the stock with a sell rating, eight have given a hold rating and two have issued a buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Hold" and a consensus target price of $155.38.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.